My Quote Request
No products added yet
6505-00-079-6759
20 Products
NDC00008-0365-FC
TYPHOID VACCINE,USP
NSN, MFG P/N
6505000796759
NSN
6505-00-079-6759
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
III EXTERIOR CONTAINER WEIGHT: 46.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TYHOID VACCINE USP 50 DOSE BT 12S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
III UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
IMMEDIATE CONTAINER QUANTITY: 1
IMMEDIATE CONTAINER TYPE: BOTTLE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 50 DOSES
SPECIAL FEATURES: ACETONE INACTIVATED; W/25 ML DILUENT
UNIT PACKAGE QUANTITY: 2
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
3941-65
ACETYL SULFAMETHOXYPYRIDAZINE ORAL SUSPENSION
NSN, MFG P/N
6505000744107
NSN
6505-00-074-4107
3941-65
ACETYL SULFAMETHOXYPYRIDAZINE ORAL SUSPENSION
NSN, MFG P/N
6505000744107
NSN
6505-00-074-4107
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS ACETYL SULFAMETHOXYPYRIDAZINE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LIBRAX
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
LIBRAX
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.574 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.40 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0007-14
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
NDC00140-0007-14
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.574 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.40 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-3490-05
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
NDC00536-3490-05
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
MFG
RUGBY GROUP INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.574 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.40 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2580-05
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
NDC00781-2580-05
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505000744692
NSN
6505-00-074-4692
MFG
SANDOZ INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.574 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 36.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.019 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.40 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE CAPSULES 500 BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00025-0061-51
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS,USP
NSN, MFG P/N
6505000744702
NSN
6505-00-074-4702
NDC00025-0061-51
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS,USP
NSN, MFG P/N
6505000744702
NSN
6505-00-074-4702
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.025 MILLIGRAMS ATROPINE SULFATE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS DIPHENOXYLATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHENOXYLATE HYDROCHLORIDE & ATROPINE SULFATE TABLETS USP 500S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
NDC00781-1262-05
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS,USP
NSN, MFG P/N
6505000744702
NSN
6505-00-074-4702
NDC00781-1262-05
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLETS,USP
NSN, MFG P/N
6505000744702
NSN
6505-00-074-4702
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.025 MILLIGRAMS ATROPINE SULFATE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS DIPHENOXYLATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIPHENOXYLATE HYDROCHLORIDE & ATROPINE SULFATE TABLETS USP 500S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
PERIDIAL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505000744910
NSN
6505-00-074-4910
PERIDIAL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505000744910
NSN
6505-00-074-4910
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.294 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER AND 70.000 MILLIGRAMS DEXTROSE PER MILLILITER AND 0.104 MILLIGRAMS SODIUM BISULFITE PER MILLILITER AND 5.650 MILLIGRAMS SODIUM CHLORIDE PER MILLILITER AND 0.488 MILLIGRAMS SODIUM LACTATE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
PERIDIAL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505000744911
NSN
6505-00-074-4911
PERIDIAL
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505000744911
NSN
6505-00-074-4911
MFG
CUTTER LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.294 MILLIGRAMS CALCIUM CHLORIDE PER MILLILITER AND 15.000 MILLIGRAMS DEXTROSE PER MILLILITER AND 0.104 MILLIGRAMS SODIUM BISULFITE PER MILLILITER AND 5.650 MILLIGRAMS SODIUM CHLORIDE PER MILLILITER AND 0.488 MILLIGRAMS SODIUM LACTATE PER MILLILITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-7801-76
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
NDC00603-7801-76
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE INGREDIENT AND STRENGTH: 3.000 CLIOQUINOL PERCENTAGE, W/W AND 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLIOQUINOL AND HYDROCORTISONE CREAM USP 20 GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
NDC45802-0006-02
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
NDC45802-0006-02
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
MFG
CLAY-PARK LABORATORIES INC
Description
ACTIVE INGREDIENT AND STRENGTH: 3.000 CLIOQUINOL PERCENTAGE, W/W AND 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLIOQUINOL AND HYDROCORTISONE CREAM USP 20 GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
NDC49158-0104-08
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
NDC49158-0104-08
CLIOQUINOL AND HYDROCORTISONE CREAM,USP
NSN, MFG P/N
6505000749912
NSN
6505-00-074-9912
MFG
THAMES PHARMACAL CO INC
Description
ACTIVE INGREDIENT AND STRENGTH: 3.000 CLIOQUINOL PERCENTAGE, W/W AND 1.000 HYDROCORTISONE PERCENTAGE, W/W
ADMINISTRATION: TOPICAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLIOQUINOL AND HYDROCORTISONE CREAM USP 20 GM TUBE
MEDICAMENT BASE TYPE: EMULSION BASE, OIL-IN-WATER
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
Related Searches:
HYGROTON
CHLORTHALIDONE TABLETS,USP
NSN, MFG P/N
6505000749914
NSN
6505-00-074-9914
MFG
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CHLORTHALIDONE ACTIVE INGREDIENT
FEATURES PROVIDED: SCORED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00070-0021-00
CHLORTHALIDONE TABLETS,USP
NSN, MFG P/N
6505000749914
NSN
6505-00-074-9914
NDC00070-0021-00
CHLORTHALIDONE TABLETS,USP
NSN, MFG P/N
6505000749914
NSN
6505-00-074-9914
MFG
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CHLORTHALIDONE ACTIVE INGREDIENT
FEATURES PROVIDED: SCORED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
0T0BI0TIC
NEOMYCIN SULFATE AND SODIUM PROPIONATE SOLUTION
NSN, MFG P/N
6505000749918
NSN
6505-00-074-9918
0T0BI0TIC
NEOMYCIN SULFATE AND SODIUM PROPIONATE SOLUTION
NSN, MFG P/N
6505000749918
NSN
6505-00-074-9918
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS SODIUM PROPIONATE EQUIVALENT AND 3.500 MILLIGRAMS NEOMYCIN EQUIVALENT
ADMINISTRATION: TOPICAL AND OTIC
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
METHERGIN
METHYLERGONOVINE MALEATE TABLETS,USP
NSN, MFG P/N
6505000753308
NSN
6505-00-075-3308
METHERGIN
METHYLERGONOVINE MALEATE TABLETS,USP
NSN, MFG P/N
6505000753308
NSN
6505-00-075-3308
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS METHYLERGONOVINE MALEATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00603-0857-60
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
NDC00603-0857-60
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN SYRUP USP 20 MG/ML 1 GL BOTTLE
III SUPPLEMENTARY FEATURES: NOTES: SUBJECT TO DAMAGE BY FREEZING; W/POTENCY PERIOD OR EXPIRATION DATE
PHARMACEUTICAL VEHICLE TYPE: HYDROALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS OR 3.78 LITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59390-0004-47
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
NDC59390-0004-47
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
MFG
ALTAIRE PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN SYRUP USP 20 MG/ML 1 GL BOTTLE
III SUPPLEMENTARY FEATURES: NOTES: SUBJECT TO DAMAGE BY FREEZING; W/POTENCY PERIOD OR EXPIRATION DATE
PHARMACEUTICAL VEHICLE TYPE: HYDROALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS OR 3.78 LITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59741-0221-20
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
NDC59741-0221-20
GUAIFENESIN SYRUP,USP
NSN, MFG P/N
6505000796269
NSN
6505-00-079-6269
MFG
BIO-PHARM INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GUAIFENESIN SYRUP USP 20 MG/ML 1 GL BOTTLE
III SUPPLEMENTARY FEATURES: NOTES: SUBJECT TO DAMAGE BY FREEZING; W/POTENCY PERIOD OR EXPIRATION DATE
PHARMACEUTICAL VEHICLE TYPE: HYDROALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS OR 3.78 LITERS
PRIMARY CONTAINER TYPE: BOTTLE
